XML 63 R51.htm IDEA: XBRL DOCUMENT v3.20.2
Stock Incentive Plans - PSO and Stock Option Activity (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
6 Months Ended
Jun. 30, 2020
Performance stock options ("PSOs")  
Number of Shares Outstanding, beginning balances 6,583
Number of Shares Outstanding, Canceled (1,377)
Number of Shares Outstanding, Exercised (948)
Number of Shares Outstanding, ending balances 4,258
Number of Shares Outstanding, expected to vest 526
Number of Shares Outstanding, exercisable 2,800
Weighted Average Exercise Price, beginning balance $ 4.54
Weighted Average Exercise Price, Canceled 6.18
Weighted Average Exercise Price, Exercised 3.61
Weighted Average Exercise Price, ending balance 4.21
Weighted Average Exercise Price, expected to vest 3.60
Weighted Average Exercise Price, exercisable $ 3.59
Weighted Average Remaining Contractual Term, ending balance 7 years 6 months 10 days
Weighted Average Remaining Contractual Term, expected to vest 7 years 4 months 6 days
Weighted Average Remaining Contractual Term, exercisable 7 years 3 months 18 days
Aggregate Intrinsic Value, ending balance $ 21,531
Aggregate Intrinsic Value, expected to vest 2,984
Aggregate Intrinsic Value, exercisable $ 15,892
Stock Options  
Number of Shares Outstanding, beginning balances 16,288
Options granted, number of shares 210
Number of Shares Outstanding, Canceled (287)
Number of Shares Outstanding, Exercised (3,460)
Number of Shares Outstanding, ending balances 12,751
Number of Shares Outstanding, exercisable 8,619
Weighted Average Exercise Price, beginning balance $ 3.56
Options granted, weighted average exercise price 9.00
Weighted Average Exercise Price, Canceled 5.35
Weighted Average Exercise Price, Exercised 3.36
Weighted Average Exercise Price, ending balance 3.66
Weighted Average Exercise Price, exercisable $ 3.28
Weighted Average Remaining Contractual Term, ending balance 6 years 11 months 23 days
Weighted Average Remaining Contractual Term, exercisable 6 years 8 months 15 days
Aggregate Intrinsic Value, ending balance $ 71,487
Aggregate Intrinsic Value, exercisable $ 51,668